Mild exposure to fine particulate matter promotes angiogenesis in non-small cell lung carcinoma

被引:1
|
作者
Ji, Su Min [1 ]
Choi, Jae-Sun [2 ,3 ]
Lee, Ji Young [1 ]
Kim, Sungyeon [4 ]
Bae, Woom-Yee [1 ,2 ]
Jang, Ye Won [1 ]
Kim, Ja-Eun [2 ,5 ]
Lee, Seung Hyeun [6 ]
Nam, Seungyoon [4 ]
Jeong, Joo-Won [1 ,2 ]
机构
[1] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul 02447, South Korea
[2] Kyung Hee Univ, Coll Med, Dept Anat & Neurobiol, 26 Kyunghee Daero, Seoul 02447, South Korea
[3] Kyung Hee Univ, Med Ctr, Clin Res Inst, Seoul 02447, South Korea
[4] Gachon Univ, Gachon Inst Genome Med & Sci, AI Convergence Ctr Med Sci, Dept Genome Med & Sci,Coll Med,Gil Med Ctr, Incheon 21565, South Korea
[5] Kyung Hee Univ, Coll Med, Dept Pharmacol, Seoul 02447, South Korea
[6] Kyung Hee Univ, Coll Med, Dept Internal Med, Div Pulm Allergy & Crit Care Med, Seoul 02447, South Korea
基金
新加坡国家研究基金会;
关键词
Fine particulate matter; Angiogenesis; Lung cancer; Hypoxia-inducible factor-1 alpha; Vascular endothelial growth factor; LONG-TERM EXPOSURE; INDUCIBLE FACTOR-I; AIR-POLLUTION; NONHYPOXIC CONDITIONS; GENE SIGNATURE; CANCER; HYPOXIA; PM2.5; MORTALITY; PROTEIN;
D O I
10.1016/j.envpol.2023.121715
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Fine particulate matter (PM2.5) is associated with public health problems worldwide. Especially, PM2.5 induces epigenetic and microenvironmental changes in lung cancer. Angiogenesis is important for the development and growth of cancer and is mediated by angiogenic factors, including vascular endothelial growth factor. However, the effects of mild PM2.5 exposure on angiogenesis in lung cancer remain unclear. In this study, we examined angiogenic effects using relatively lower concentrations of PM2.5 than in other studies and found that PM2.5 increased angiogenic activities in both endothelial cells and non-small cell lung carcinoma cells. PM2.5 also promoted the growth and angiogenesis of lung cancer via the induction of hypoxia-inducible factor-1a (HIF-1a) in a xenograft mouse tumor model. Angiogenic factors, including vascular endothelial growth factor (VEGF), were highly expressed in lung cancer patients in countries with high PM2.5 levels in the atmosphere, and high expression of VEGF in lung cancer patients lowered the survival rate. Collectively, these results provide new insight into the mechanisms by which mild exposure to PM2.5 is involved in HIF-1a-mediated angiogenesis in lung cancer patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer
    Guangmei Mao
    Yan Liu
    Xi Fang
    Yahan Liu
    Li Fang
    Lianjun Lin
    Xinmin Liu
    Nanping Wang
    Angiogenesis, 2015, 18 : 373 - 382
  • [22] Transcriptional repressor Snail promotes tumor growth and angiogenesis in human non-small cell lung cancer
    Yanagawa, Jane
    Walser, Tonya C.
    Lee, Jay M.
    Dohadwala, Mariam
    Zhu, Li X.
    Krysan, Kostyantyn
    Luo, Jie
    Sharma, Sherven
    Dubinett, Steven M.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2008, 207 (03) : S47 - S47
  • [23] Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer
    Mao, Guangmei
    Liu, Yan
    Fang, Xi
    Liu, Yahan
    Fang, Li
    Lin, Lianjun
    Liu, Xinmin
    Wang, Nanping
    ANGIOGENESIS, 2015, 18 (03) : 373 - 382
  • [24] Histopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumors
    Dorantes-Heredia, Rita
    Manuel Ruiz-Morales, Jose
    Cano-Garcia, Fernando
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (04) : 401 - 412
  • [25] CHEMOTHERAPY OF NON-SMALL CELL-CARCINOMA OF LUNG
    TATTERSALL, MHN
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1978, 8 (04): : 451 - 452
  • [26] Early stage non-small cell Lung carcinoma
    Eberhardt, Wilfried
    Griesinger, Frank
    Filipits, Martin
    Winter, Hauke
    ONKOLOGIE, 2012, 35 : 6 - 9
  • [27] THE PATHOLOGY OF NON-SMALL CELL-CARCINOMA OF THE LUNG
    MATTHEWS, MJ
    MACKAY, B
    LUKEMAN, J
    SEMINARS IN ONCOLOGY, 1983, 10 (01) : 34 - 55
  • [28] Predictive immunocytochemistry in non-small cell lung carcinoma
    Brcic, Luka
    Prince, Spasenija Savic
    PATHOLOGIE, 2022, 43 (03): : 222 - 228
  • [29] Predictive immunocytochemistry in non-small cell lung carcinoma
    Brcic, Luka
    Prince, Spasenija Savic
    PATHOLOGE, 2022, 43 (03): : 222 - 228
  • [30] KRAS Amplification in Non-Small Cell Lung Carcinoma
    Stiedl, A. C.
    Wagner, P. L.
    Wilbertz, T.
    Altorki, N. K.
    Perner, S. R.
    LABORATORY INVESTIGATION, 2010, 90 : 414A - 414A